Gene Query: L3HYPDH

Dataset Description Geneva Score
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 23.02
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 14.72
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 13.07
Identification of Nrf2 regulated genes by RNA sequencing 12.76
Nrf2 regulated genes in A549 cells 12.76
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 11.89
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 11.58
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 10.11
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 9.64
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 9.64
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 9.42
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 9.06
Glioblastoma stem cells infected by ZIKA virus 8.18
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 7.75
Paxillin regulates genomic networks in prostate cancer [PC3] 7.72
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.61
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 6.32
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 6.29
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 6.06
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.97
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.46
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.46
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 5.43
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 5.35
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 5.34
6mer seed toxicity in tumour suppressive microRNAs 5.14
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.14
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.0
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.0
RNA-seq of human fibroblasts after irradiation 4.89
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 4.8
An optimization system for isolating and sequencing of single human colon cancer cells 4.69
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 4.65
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.61
N6-methyladenine DNA Modification in Glioblastoma 4.61
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.59
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.59
HNRNPL and its RNA Targets in Prostate Cancer 4.58
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 4.58
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 4.44
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 4.43
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 4.31
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 4.26
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 4.22
Control of prostate tumour growth by the long non-coding RNA GHSROS 4.16
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.03
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.02
RNAseq Analysis in glioblastoma cells treated with Mepazine 3.95
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.93
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.93
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.83
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 3.75
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 3.73
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 3.69
RNA expression following TMPRSS11B overexpression or depletion 3.68
RNA sequencing of human mammary epithelial cells 3.61
RNA-seq analyses of human prostate cancer cells 3.57
FOXP1 orchestration of ASD-relevant signaling pathways. 3.53
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.49
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.49
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 3.49
The cohesin complex prevents Myc-induced replication stress 3.48
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 3.32
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.28
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.27
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 3.27
Polarized B -cell functions 3.24
Tumor exosome integrins determine organotropic metastasis 3.22
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 3.22
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 3.18
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 3.16
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 3.15
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.14
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 3.11
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 3.11
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.11
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 3.07
Genome-wide chromatin analysis of Ewing sarcoma 3.01
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.01
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 3.01
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.01
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.01
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.92
The regulartory role of ZCCHC24 in splicing machinery 2.91
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 2.9
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 2.86
A549 cells and MSR-A549 cells 2.86
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 2.81
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.77
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.77
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.74
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.74
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.73
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.73
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 2.72
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.71
Differential gene expression in Jagged1 treated human dental pulp cells. 2.69
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.69
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.62
A role for ZNF598 in post-transcriptional gene regulation 2.61
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 2.6
Proliferation-correlated expression 2.59
High-Throughput Kinetic Analysis of Fractional Killing 2.56
Cleavage Factor Im as a key regulator of 3’ UTR length 2.55
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 2.54
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.51
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 2.47
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 2.47
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 2.45
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.44
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 2.4
Characterization of human ILC2 subsets 2.4
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 2.39
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 2.39
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 2.37
RNA editing in nascent RNA affects pre-mRNA splicing 2.36
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.36
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.35
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.35
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.34
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.34
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 2.31
Bone marrow derived human B cells [normal proB] 2.29
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.25
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 2.23
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 2.22
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.21
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 2.2
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.2
Gene expression of thyroid cancer cell lines 2.19
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 2.16
PNET animal model: new insights (II) 2.15
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 2.15
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 2.15
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 2.12
KLF6-dependent transcription in renal cancer cells 2.11
MeRIP-seq for heat shock in B-cell lymphoma cells 2.1
Gene expression in GBM with Cav3.2 inhibition 2.08
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 2.08
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 2.07
Transcriptional profiles of normal human mature B cells 2.04
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 2.04
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.03
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.97
Single-Cell Genotyping of Transcriptomes 1.97
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.93
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.93
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.92
NRDE2 negatively regulates nuclear exosome functions 1.92
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 1.9
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.9
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.88
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.87
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 1.86
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.86
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.85
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.85
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 1.84
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 1.84
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 1.82
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.82
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 1.79
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 1.77
Toxoplasma gondii infection of human retinal pigment epithelial cells 1.76
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.76
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 1.76
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.76
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.76
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.75
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.75
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 1.75
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 1.73
TGF-β promotes genomic instability after loss of RUNX3 1.7
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.69
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.69
Single-cell analysis of adult human ovary using 10X genomics 1.68
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 1.67
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 1.65
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.65
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 1.65
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 1.65
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 1.65
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.65
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.63
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.62
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.61
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 1.6
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 1.6
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 1.6
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 1.6
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 1.6
IL-33 activates tumor stroma to promote intestinal polyposis 1.59
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 1.59
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 1.59
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.58
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 1.57
Gene expression signatures of innate lymphoid cells from human blood 1.56
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 1.54
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 1.54
Be1 and Be2 B cells are transcriptionally distinct 1.54
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 1.52
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 1.52
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.52
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.52
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.52
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 1.52
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.49
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 1.49
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 1.47
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 1.46
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 1.46
A transcriptome-wide divergence in protein translation scales with LIN28B expression 1.46
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 1.46
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 1.45
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 1.45
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 1.44
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 1.44
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.43
HNRNPM-regulated splicing dependencies in prostate cancer 1.43
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.43
Modeling Familial Cancer with iPSC Approaches 1.42
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.41
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.41
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.41
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 1.39
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 1.39
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 1.38
RNA-sequencing in irradiated and normal A549 cells. 1.38
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.38
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 1.38
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.37
Inhibition of TNBC metastasis by Gpx1 1.37
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.36
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.36
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.36
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.36
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 1.35
Noncoding regions are the main source of targetable tumor-specific antigens 1.35
Regulation of protein translation during mitosis 1.33
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.33
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.33
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 1.31
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.31
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.31
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.3
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.29
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.29
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.29
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.29
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.29
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.29
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 1.29
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 1.29
RNA splicing alteration on glioblastoma and normal neural stem cells 1.28
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 1.28
RNA-sequencing in immortalized human mammary epithelial cells 1.28
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.27
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 1.27
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.26
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 1.25
Analysis of transcriptional regulation by Myt1 and Myt1l 1.25
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 1.25
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.25
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.24
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.23
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 1.23
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.23
Gene Expression Profiling of SPOP Knocked Down Cell 1.22
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.22
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.22
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.21
Nucleoporin-mediated regulation of cell identity genes 1.2
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 1.2
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.2
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.2
Capturing the Interactome of Newly Transcribed RNA 1.19
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.19
Chromatin landscape of human visceral and subcutaneous adipocytes 1.19
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.17
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 1.16
MYC dependent mRNA translation shapes gene expression and cell biology 1.16
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 1.16
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 1.16
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.15
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 1.15
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 1.14
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 1.13
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.13
Characterization of parental and rociletinib-resistant derived H1975 cell lines 1.12
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.12
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.11
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 1.1
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.1
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.1
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.1
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.09
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.08
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 1.08
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 1.07
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 1.06
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.06
RNA-sequencing of healthy human skeletal myocytes 1.05
A549 cell transcriptome responses to infection with H7N9 influenza virus 1.05
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 1.05
NHLRC1 re-expression in cancer cells 1.05
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 1.05
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 1.05
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.04
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.04
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.03
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.02
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 1.02
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 1.02
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 1.01
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.0
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.0
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.99
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.99
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 0.99
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.97
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.97
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.97
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 0.96
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.96
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 0.95
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 0.95
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.95
Induced DNA demethylation, genome instability and transcription 0.95
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.94
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 0.93
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 0.92
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 0.91
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.9
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.89
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 0.88
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 0.87
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.87
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.85
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.85
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.85
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 0.83
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.83
Hepatocyte maturation 0.81
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.81
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.81
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 0.8
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 0.77
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.77
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.77
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.77
Activity-dependent transcriptional changes in human neurons 0.77
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.76
RNA-seq analysis upon ARID1B overexpression 0.74
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 0.73
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.73
Gene expression profile in breast cancer cells 0.72
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.72
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.72
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.72
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.71
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.71
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.71
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.7
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.7
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 0.68
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.67
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.67
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.67
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 0.67
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.67
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.66
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.66
MAIT cell RNA sequencing 0.64
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.64
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.63
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.63
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.62
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.62
Identification of Sin3B regulated genes during quiescence 0.61
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.59
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.59
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.58
RNA-Seq in PWS iPSC-derived neurons 0.57
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.56
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.56
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.56
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.55
CHD1 regulates cell fate determination by activation of differentiation-induced genes 0.54
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.53
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 0.52
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.52
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.51
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.51
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.5
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.48
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 0.48
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.48
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.48
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.48
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.48
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 0.48
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.47
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.46
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.46
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.46
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.46
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 0.45
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.45
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.45
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.44
Investigate A2M treatment on human prostate cancer and mouse liver 0.44
Investigate A2M treatment on human prostate cancer xenograft in mice 0.44
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.42
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.42
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.42
Functional astrocytes differentiated from hiPSCs 0.41
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.41
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.41
Ebola virus (EBOV) infection of ARPE-19 cells 0.39
Transcriptome Profiling of Human Primary Monocytes 0.39
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.37
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.37
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.36
quanTIseq: quantifying immune contexture of human tumors 0.36
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 0.35
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.33
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.33
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.31
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 0.3
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.29
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.29
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.28
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.28
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.28
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.28
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.27
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 0.27
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.27
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.26
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.25
Genome-wide analysis of Dengue virus 2 infected cells 0.24
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.23
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.22
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.22
Gene expression changes due to PARP knockdown in human cells 0.22
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.21
Gene expression of collecting duct carcinoma of the kidney 0.21
Leucegene: AML sequencing (part 6) 0.21
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.21
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.21
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.21
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 0.2
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.2
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 0.2
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.19
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.18
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.18
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.18
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.17
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.17
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.15
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.15
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.14
Gene expression analysis of human hepatocellular cancers 0.13
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.13
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.12
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.12
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.12
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.11
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.11
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.11
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.11
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.11
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.11
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.1
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.1
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.1
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.09
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.09
RNA-Seq and expression data from human adipose tissue 0.09
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.08
Molecular analysis of renal cell carcinoma with unclassfied histology 0.08
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.08
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.08
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.07
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.07
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.06
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.06
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.05
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.05
The transcriptome and chromatin accessbility landscape of mammalian germline 0.04
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.03
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 0.03
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 0.03
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 0.02
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.01
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.01
FOXP2's impact on the primate transcriptome 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation